The Inspiromatic DPI utilizes breakthrough technology that overcomes the drawbacks of current dry powder inhalers.
- Its active mechanism delivers fine drug powder particles at a flow rate as low as 6L/min.
- The built-in real-time feedback interface ensures proper use.
- Automatic data logger facilitates physicians’ follow-up for improved patient compliance.
Inspiro Medical has successfully demonstrated Inspiromatic’s novel technology for improved drug deposition in the lung.